A cross-sectional study of 154 chimpanzees aged 12–57 found age-related blood and brain patterns resembling those seen in humans.A cross-sectional study of 154 chimpanzees aged 12–57 found age-related blood and brain patterns resembling those seen in humans.
A blood marker of nerve-fiber damage statistically accounted for 18.05% of the link between depressive symptoms and poorer later cognitive performance.A blood marker of nerve-fiber damage statistically accounted for 18.05% of the link between depressive symptoms and poorer later cognitive performance.
An observational study of 644 older adults linked an elevated Alzheimer's blood marker to subtle differences in thinking, behavior and body function.An observational study of 644 older adults linked an elevated Alzheimer's blood marker to subtle differences in thinking, behavior and body function.
One modified form of tau averaged 17 picograms per milliliter in newborns, versus 8.6 in Alzheimer’s patients and 2.6 in older controls.One modified form of tau averaged 17 picograms per milliliter in newborns, versus 8.6 in Alzheimer’s patients and 2.6 in older controls.
In a 15-year study of 1,492 older adults, an elevated Alzheimer’s-related blood marker tracked with progressively larger blood pressure drops upon standing.In a 15-year study of 1,492 older adults, an elevated Alzheimer’s-related blood marker tracked with progressively larger blood pressure drops upon standing.
In an observational study of 491 hospitalized heart failure patients followed for a median 3.6 years, two markers of cognitive decline were associated with all-cause…In an observational study of 491 hospitalized heart failure patients followed for a median 3.6 years, two markers of cognitive decline were associated with all-cause mortality.
Each doubling of the marker’s blood level was linked to higher mortality, with an adjusted hazard ratio—a relative-risk measure—of 1.91.Each doubling of the marker’s blood level was linked to higher mortality, with an adjusted hazard ratio—a relative-risk measure—of 1.91.
Over a median 12.2 years, the markers identified 41.7%–59.5% of people who received a dementia diagnosis.Over a median 12.2 years, the markers identified 41.7%–59.5% of people who received a dementia diagnosis.
In an observational study of 755 people, the link between a blood marker and cognitive decline varied with a protein associated with Alzheimer’s disease.In an observational study of 755 people, the link between a blood marker and cognitive decline varied with a protein associated with Alzheimer’s disease.
An observational analysis of 594 and 475 cognitively normal adults found different blood-protein patterns depending on which Alzheimer's test was positive.An observational analysis of 594 and 475 cognitively normal adults found different blood-protein patterns depending on which Alzheimer's test was positive.